236 related articles for article (PubMed ID: 38312103)
1. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn's disease.
Han B; Tang D; Lv X; Fan J; Li S; Zhu H; Zhang J; Xu S; Xu X; Huang Z; Huang Z; Lin G; Zhan L; Lv X
Gut Microbes; 2024; 16(1):2310894. PubMed ID: 38312103
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.
Han B; Lv X; Liu G; Li S; Fan J; Chen L; Huang Z; Lin G; Xu X; Huang Z; Zhan L; Lv X
Gut Microbes; 2023; 15(1):2232143. PubMed ID: 37431863
[TBL] [Abstract][Full Text] [Related]
3. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
[TBL] [Abstract][Full Text] [Related]
4. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis.
Yang ZH; Liu F; Zhu XR; Suo FY; Jia ZJ; Yao SK
World J Gastroenterol; 2021 Jun; 27(24):3609-3629. PubMed ID: 34239273
[TBL] [Abstract][Full Text] [Related]
5. Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.
Kumar A; Al-Hassi HO; Steed H; Phipps O; Brookes MJ
Can J Gastroenterol Hepatol; 2022; 2022():8416578. PubMed ID: 35360442
[TBL] [Abstract][Full Text] [Related]
6. Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease.
Ding NS; McDonald JAK; Perdones-Montero A; Rees DN; Adegbola SO; Misra R; Hendy P; Penez L; Marchesi JR; Holmes E; Sarafian MH; Hart AL
J Crohns Colitis; 2020 Sep; 14(8):1090-1102. PubMed ID: 32119090
[TBL] [Abstract][Full Text] [Related]
7. Location-specific signatures of Crohn's disease at a multi-omics scale.
Gonzalez CG; Mills RH; Zhu Q; Sauceda C; Knight R; Dulai PS; Gonzalez DJ
Microbiome; 2022 Aug; 10(1):133. PubMed ID: 35999575
[TBL] [Abstract][Full Text] [Related]
8. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights.
Foligné B; Plé C; Titécat M; Dendooven A; Pagny A; Daniel C; Singer E; Pottier M; Bertin B; Neut C; Deplanque D; Dubuquoy L; Desreumaux P; Capron M; Standaert A
Cells; 2019 Jun; 8(6):. PubMed ID: 31212833
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota.
Yang F; Ni B; Liu Q; He F; Li L; Zhong X; Zheng X; Lu J; Chen X; Lin H; Xu R; He Y; Zhang Q; Zou X; Chen W
Stem Cell Res Ther; 2022 Sep; 13(1):475. PubMed ID: 36104756
[TBL] [Abstract][Full Text] [Related]
11. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
[TBL] [Abstract][Full Text] [Related]
12. Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling.
Zhang Z; Zuo L; Song X; Wang L; Zhang Y; Cheng Y; Huang J; Zhao T; Yang Z; Zhang H; Li J; Zhang X; Geng Z; Wang Y; Ge S; Hu J
Phytomedicine; 2024 Jan; 123():155223. PubMed ID: 38134862
[TBL] [Abstract][Full Text] [Related]
13. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience.
Erdoğan Ç; Yeşil B; Bacaksız F; Arı D; Gökbulut V; Yüksel M; Özderin Özin Y; Kayaçetin E
Turk J Gastroenterol; 2022 Oct; 33(10):831-837. PubMed ID: 35946879
[TBL] [Abstract][Full Text] [Related]
14. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
[TBL] [Abstract][Full Text] [Related]
15. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
[TBL] [Abstract][Full Text] [Related]
16. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives.
Li M; Yang L; Mu C; Sun Y; Gu Y; Chen D; Liu T; Cao H
Comput Struct Biotechnol J; 2022; 20():2402-2414. PubMed ID: 35664229
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease.
Lee JWJ; Plichta D; Hogstrom L; Borren NZ; Lau H; Gregory SM; Tan W; Khalili H; Clish C; Vlamakis H; Xavier RJ; Ananthakrishnan AN
Cell Host Microbe; 2021 Aug; 29(8):1294-1304.e4. PubMed ID: 34297922
[TBL] [Abstract][Full Text] [Related]
18. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis.
Wu J; Wei Z; Cheng P; Qian C; Xu F; Yang Y; Wang A; Chen W; Sun Z; Lu Y
Theranostics; 2020; 10(23):10665-10679. PubMed ID: 32929373
[No Abstract] [Full Text] [Related]
19. Dual role for microbial short-chain fatty acids in modifying SIV disease trajectory following anti-α4β7 antibody administration.
Johnson SD; Pilli N; Yu J; Knight LA; Kane MA; Byrareddy SN
Ann Med; 2024 Dec; 56(1):2315224. PubMed ID: 38353210
[TBL] [Abstract][Full Text] [Related]
20. Fucose Ameliorate Intestinal Inflammation Through Modulating the Crosstalk Between Bile Acids and Gut Microbiota in a Chronic Colitis Murine Model.
Ke J; Li Y; Han C; He R; Lin R; Qian W; Hou X
Inflamm Bowel Dis; 2020 May; 26(6):863-873. PubMed ID: 32010956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
